应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02480 绿竹生物-B
未开盘 07-11 16:08:03
21.500
-0.800
-3.59%
最高
22.300
最低
21.050
成交量
8,000
今开
22.300
昨收
22.300
日振幅
5.61%
总市值
42.79亿
流通市值
42.79亿
总股本
1.99亿
成交额
17.01万
换手率
0.00%
流通股本
1.99亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
绿竹生物-B盘中异动 股价大跌5.38%报21.100港元
市场透视 · 07-11 03:21
绿竹生物-B盘中异动 股价大跌5.38%报21.100港元
绿竹生物-B盘中异动 早盘股价大跌10.79%报21.500港元
市场透视 · 07-07
绿竹生物-B盘中异动 早盘股价大跌10.79%报21.500港元
绿竹生物-B(02480)指定侯爱军担任首席独立非执行董事
智通财经 · 06-27
绿竹生物-B(02480)指定侯爱军担任首席独立非执行董事
绿竹生物-B盘中异动 临近收盘股价大跌5.62%
市场透视 · 06-19
绿竹生物-B盘中异动 临近收盘股价大跌5.62%
绿竹生物-B盘中异动 股价大涨5.93%报25.000港元
市场透视 · 06-17
绿竹生物-B盘中异动 股价大涨5.93%报25.000港元
绿竹生物-B(02480)委任彭玲为执行董事
智通财经 · 06-12
绿竹生物-B(02480)委任彭玲为执行董事
绿竹生物-B盘中异动 股价大跌6.12%
市场透视 · 06-11
绿竹生物-B盘中异动 股价大跌6.12%
绿竹生物-B盘中异动 早盘急速拉升5.93%
市场透视 · 06-09
绿竹生物-B盘中异动 早盘急速拉升5.93%
绿竹生物-B盘中异动 下午盘股价大涨5.41%
市场透视 · 06-04
绿竹生物-B盘中异动 下午盘股价大涨5.41%
绿竹生物-B盘中异动 下午盘股价大涨8.13%报21.950港元
市场透视 · 05-28
绿竹生物-B盘中异动 下午盘股价大涨8.13%报21.950港元
绿竹生物-B盘中异动 急速拉升5.45%报21.300港元
市场透视 · 05-26
绿竹生物-B盘中异动 急速拉升5.45%报21.300港元
港股生物科技股午后持续走强,绿竹生物-B涨超19%
老虎资讯综合 · 05-19
港股生物科技股午后持续走强,绿竹生物-B涨超19%
绿竹生物-B盘中异动 大幅上涨7.14%
市场透视 · 05-19
绿竹生物-B盘中异动 大幅上涨7.14%
港股生物医药股集体走强,绿竹生物-B涨超10%
老虎资讯综合 · 05-16
港股生物医药股集体走强,绿竹生物-B涨超10%
绿竹生物-B盘中异动 股价大涨6.51%
市场透视 · 05-15
绿竹生物-B盘中异动 股价大涨6.51%
绿竹生物-B盘中异动 急速下挫5.68%报20.750港元
市场透视 · 05-08
绿竹生物-B盘中异动 急速下挫5.68%报20.750港元
核心带疱疫苗或在明年上市,能否将绿竹生物-B(02480)拖出“流动性陷阱”?
智通财经 · 05-07
核心带疱疫苗或在明年上市,能否将绿竹生物-B(02480)拖出“流动性陷阱”?
绿竹生物-B盘中异动 股价大跌7.95%报20.250港元
市场透视 · 05-06
绿竹生物-B盘中异动 股价大跌7.95%报20.250港元
绿竹生物-B(02480)5月2日斥资3971.33万港元回购175.92万股
智通财经 · 05-02
绿竹生物-B(02480)5月2日斥资3971.33万港元回购175.92万股
绿竹生物-B股价重挫10.20% 市值跌4.51亿港元
市场透视 · 04-30
绿竹生物-B股价重挫10.20% 市值跌4.51亿港元
加载更多
公司概况
公司名称:
绿竹生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
北京绿竹生物技术股份有限公司是一家主要从事疫苗及治疗性生物制剂的研究、开发及生产的中国公司。该公司还从事开发创新型人用疫苗及治疗性生物制剂,以预防及控制传染病以及治疗癌症及自身免疫性疾病。该公司的产品包括临床阶段的在研产品,以及临床前阶段的在研产品。核心产品LZ901,主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司主要在国内市场开展其业务
发行价格:
--
{"stockData":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"绿竹生物-B","latestPrice":21.5,"timestamp":1752221283030,"preClose":22.3,"halted":0,"volume":8000,"delay":0,"floatShares":199000000,"shares":199000000,"eps":-0.9125152936023234,"marketStatus":"未开盘","change":-0.8,"latestTime":"07-11 16:08:03","open":22.3,"high":22.3,"low":21.05,"amount":170110,"amplitude":0.056054,"askPrice":22.3,"askSize":200,"bidPrice":21.5,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-0.9125152936023234,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":0,"adr":0,"listingDate":1683475200000,"exchange":"SEHK","adjPreClose":22.3,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":1.020408152852978,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02480","defaultTab":"news","newsList":[{"id":"2550147604","title":"绿竹生物-B盘中异动 股价大跌5.38%报21.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550147604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550147604?lang=zh_cn&edition=full","pubTime":"2025-07-11 11:21","pubTimestamp":1752204090,"startTime":"0","endTime":"0","summary":"2025年07月11日早盘11时21分,绿竹生物-B股票出现波动,股价大幅下跌5.38%。截至发稿,该股报21.100港元/股,成交量4800股,换手率0.00%,振幅5.61%。资金方面,该股资金流入0港元,流出2.611万港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为2.66%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071111213097a1c1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071111213097a1c1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2549306209","title":"绿竹生物-B盘中异动 早盘股价大跌10.79%报21.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549306209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549306209?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:13","pubTimestamp":1751858022,"startTime":"0","endTime":"0","summary":"2025年07月07日早盘11时13分,绿竹生物-B股票出现波动,股价快速下挫10.79%。截至发稿,该股报21.500港元/股,成交量3600股,换手率0.00%,振幅9.13%。资金方面,该股资金流入0港元,流出7.958万港元。绿竹生物-B股票所在的生物技术行业中,整体跌幅为1.74%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707111342a69a0bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707111342a69a0bef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2546710673","title":"绿竹生物-B(02480)指定侯爱军担任首席独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2546710673","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546710673?lang=zh_cn&edition=full","pubTime":"2025-06-27 19:00","pubTimestamp":1751022020,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B(02480)发布公告,董事会已指定独立非执行董事侯爱军女士担任首席独立非执行董事一职,自2025年6月27日起生效。首席独立非执行董事并非公司的行政职位,且不担任集团的任何管理角色。侯爱军女士于董事会及相关董事会委员会担任的其他职位维持不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2544153165","title":"绿竹生物-B盘中异动 临近收盘股价大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544153165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544153165?lang=zh_cn&edition=full","pubTime":"2025-06-19 15:30","pubTimestamp":1750318252,"startTime":"0","endTime":"0","summary":"2025年06月19日临近收盘15时30分,绿竹生物-B股票出现波动,股价大幅跳水5.62%。截至发稿,该股报23.500港元/股,成交量400股,换手率0.00%,振幅5.62%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为3.85%。其相关个股中,帝王国际投资、云康集团、荃信生物-B涨幅较大,振幅较大的相关个股有北海康成-B、帝王国际投资、云康集团,振幅分别为19.48%、16.50%、12.57%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061915305297862a3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061915305297862a3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2544935840","title":"绿竹生物-B盘中异动 股价大涨5.93%报25.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544935840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544935840?lang=zh_cn&edition=full","pubTime":"2025-06-17 10:40","pubTimestamp":1750128033,"startTime":"0","endTime":"0","summary":"2025年06月17日早盘10时40分,绿竹生物-B股票出现波动,股价急速上涨5.93%。截至发稿,该股报25.000港元/股,成交量6200股,换手率0.00%,振幅6.14%。资金方面,该股资金流入22.812万港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体跌幅为2.02%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506171040339782b6a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506171040339782b6a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2542512034","title":"绿竹生物-B(02480)委任彭玲为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2542512034","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542512034?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:35","pubTimestamp":1749735324,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B 公布,于年度股东会上,孔健先生及张琰平女士均获重选为第五届董事会执行董事,彭玲女士获选举为第五届董事会执行董事,马骉先生及孔双泉先生均获重选为第五届董事会非执行董事,以及梁伟业先生、梁冶矢先生及侯爱军女士均获重选为第五届董事会独立非执行董事。然而,蒋先敏女士将仍为集团雇员。第四届监事会监事彭玲女士已于年度股东会上获选举为第五届董事会执行董事,并将于2025年9月15日退任监事职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1304681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2542305813","title":"绿竹生物-B盘中异动 股价大跌6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542305813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542305813?lang=zh_cn&edition=full","pubTime":"2025-06-11 15:56","pubTimestamp":1749628591,"startTime":"0","endTime":"0","summary":"2025年06月11日临近收盘15时56分,绿竹生物-B股票出现波动,股价急速下挫6.12%。截至发稿,该股报23.000港元/股,成交量4.3万股,换手率0.02%,振幅6.12%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.82%。其相关个股中,方达控股、基石药业-B、乐普生物-B涨幅较大,振幅较大的相关个股有北海康成-B、方达控股、中国抗体-B,振幅分别为21.23%、18.42%、16.67%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611155631a7034f06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611155631a7034f06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2542873128","title":"绿竹生物-B盘中异动 早盘急速拉升5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542873128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542873128?lang=zh_cn&edition=full","pubTime":"2025-06-09 09:42","pubTimestamp":1749433333,"startTime":"0","endTime":"0","summary":"2025年06月09日早盘09时42分,绿竹生物-B股票出现波动,股价急速上涨5.93%。其相关个股中,中国抗体-B、帝王国际投资、金斯瑞生物科技涨幅较大,振幅较大的相关个股有中国抗体-B、药明巨诺-B、基石药业-B,振幅分别为15.96%、7.14%、6.39%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060909421395140103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060909421395140103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2540303491","title":"绿竹生物-B盘中异动 下午盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540303491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540303491?lang=zh_cn&edition=full","pubTime":"2025-06-04 15:03","pubTimestamp":1749020604,"startTime":"0","endTime":"0","summary":"2025年06月04日下午盘15时03分,绿竹生物-B股票出现异动,股价急速拉升5.41%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为3.15%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060415032597710f1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060415032597710f1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2538544370","title":"绿竹生物-B盘中异动 下午盘股价大涨8.13%报21.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538544370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538544370?lang=zh_cn&edition=full","pubTime":"2025-05-28 13:02","pubTimestamp":1748408557,"startTime":"0","endTime":"0","summary":"2025年05月28日下午盘13时02分,绿竹生物-B股票出现波动,股价快速上涨8.13%。截至发稿,该股报21.950港元/股,成交量1400股,换手率0.00%,振幅5.67%。资金方面,该股资金流入2.947万港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体跌幅为1.46%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528130237a48f428d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528130237a48f428d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2538122832","title":"绿竹生物-B盘中异动 急速拉升5.45%报21.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538122832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538122832?lang=zh_cn&edition=full","pubTime":"2025-05-26 14:21","pubTimestamp":1748240512,"startTime":"0","endTime":"0","summary":"2025年05月26日下午盘14时21分,绿竹生物-B股票出现异动,股价大幅拉升5.45%。截至发稿,该股报21.300港元/股,成交量2000股,换手率0.00%,振幅6.19%。资金方面,该股资金流入1.24万港元,流出2.957万港元。绿竹生物-B股票所在的生物技术行业中,整体跌幅为1.45%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526142152a48c8d1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526142152a48c8d1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"1146836428","title":"港股生物科技股午后持续走强,绿竹生物-B涨超19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146836428","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146836428?lang=zh_cn&edition=full","pubTime":"2025-05-19 14:58","pubTimestamp":1747637903,"startTime":"0","endTime":"0","summary":"5月19日,港股生物医药股多数走强,$四环医药(00460)$涨超16%,$先声药业(02096)$涨超7%,欧康维视生物、$再鼎医药(ZLAB)$、$诺诚健华(09969)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b136a5dcc9908cfc39153f845e631c9a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480","HSCEI","HSTECH","BK1161","07226","BK4614","159837","YANG"],"gpt_icon":0},{"id":"2536268675","title":"绿竹生物-B盘中异动 大幅上涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536268675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536268675?lang=zh_cn&edition=full","pubTime":"2025-05-19 10:53","pubTimestamp":1747623230,"startTime":"0","endTime":"0","summary":"2025年05月19日早盘10时53分,绿竹生物-B股票出现波动,股价大幅上涨7.14%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.71%。其相关个股中,欧康维视生物-B、康宁杰瑞制药-B、云顶新耀涨幅较大,振幅较大的相关个股有正大企业国际、欧康维视生物-B、创胜集团-B,振幅分别为20.69%、13.81%、13.08%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051910535094fb02c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051910535094fb02c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"1187897028","title":"港股生物医药股集体走强,绿竹生物-B涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187897028","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187897028?lang=zh_cn&edition=full","pubTime":"2025-05-16 09:37","pubTimestamp":1747359426,"startTime":"0","endTime":"0","summary":"5月16日,港股生物医药股集体走强,$绿竹生物-B(02480)$、$北海康成-B(01228)$涨超10%,$中国抗体-B(03681)$涨超7%,$再鼎医药(09688)$、$康希诺生物(06185)$涨近4%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b136a5dcc9908cfc39153f845e631c9a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480","06185","BK1515","BK4585","01228","YANG","HSCEI","LU2488822045.USD","BK4548","BK4526","07226","BK4588","03681","09688","BK1588","ZLAB","BK1161","BK4531","HSTECH","BK4614"],"gpt_icon":0},{"id":"2535868244","title":"绿竹生物-B盘中异动 股价大涨6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535868244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535868244?lang=zh_cn&edition=full","pubTime":"2025-05-15 13:15","pubTimestamp":1747286142,"startTime":"0","endTime":"0","summary":"2025年05月15日下午盘13时15分,绿竹生物-B股票出现波动,股价急速上涨6.51%。截至发稿,该股报22.900港元/股,成交量7400股,换手率0.00%,振幅4.19%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.81%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515131542aa2c8f62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515131542aa2c8f62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2533914702","title":"绿竹生物-B盘中异动 急速下挫5.68%报20.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533914702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533914702?lang=zh_cn&edition=full","pubTime":"2025-05-08 10:31","pubTimestamp":1746671484,"startTime":"0","endTime":"0","summary":"2025年05月08日早盘10时31分,绿竹生物-B股票出现波动,股价急速下挫5.68%。截至发稿,该股报20.750港元/股,成交量200股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出4150港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.06%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。对此,百克生物表示,主要系本报告期带状疱疹疫苗销量减少所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508103125aa2c86c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508103125aa2c86c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2533616225","title":"核心带疱疫苗或在明年上市,能否将绿竹生物-B(02480)拖出“流动性陷阱”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2533616225","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533616225?lang=zh_cn&edition=full","pubTime":"2025-05-07 09:29","pubTimestamp":1746581356,"startTime":"0","endTime":"0","summary":"对此,百克生物表示,主要系本报告期带状疱疹疫苗销量减少所致。然而,受到百克生物此次年报业绩表现打击最大的似乎并非百克本身,而是尚未实现产品收入且核心带疱疫苗即将上市的绿竹生物-B。今年一季度,国内疫苗行业上市公司似乎集体遭遇了“滑铁卢”。回到带疱疫苗,其实目前市场竞争环境良好,因为仅有百克生物的感维和GSK的Shingrix上市,如果绿竹生物的LZ901能够按预期的2026年上半年前后商业化,便可成为国内第三款带疱疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","BK1161","02480"],"gpt_icon":0},{"id":"2533542602","title":"绿竹生物-B盘中异动 股价大跌7.95%报20.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533542602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533542602?lang=zh_cn&edition=full","pubTime":"2025-05-06 09:48","pubTimestamp":1746496126,"startTime":"0","endTime":"0","summary":"2025年05月06日早盘09时48分,绿竹生物-B股票出现波动,股价大幅下跌7.95%。截至发稿,该股报20.250港元/股,成交量1200股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出2.43万港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.54%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609484694ed618f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609484694ed618f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2532481468","title":"绿竹生物-B(02480)5月2日斥资3971.33万港元回购175.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2532481468","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532481468?lang=zh_cn&edition=full","pubTime":"2025-05-02 18:51","pubTimestamp":1746183090,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B(02480)发布公告,于2025年5月2日斥资3971.33万港元回购股份175.92万股,每股回购价格为21.95-23港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2531772732","title":"绿竹生物-B股价重挫10.20% 市值跌4.51亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531772732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531772732?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:15","pubTimestamp":1745993720,"startTime":"0","endTime":"0","summary":"2025年04月30日下午盘14时15分,绿竹生物-B股票出现波动,股价快速跳水10.20%。截至发稿,该股报22.000港元/股,成交量800股,换手率0.00%,振幅10.00%。资金方面,该股资金流入1.831万港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为1.70%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043014152094e88a81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043014152094e88a81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0}],"profile":{"websiteUrl":"http://luzhubiotech.com","stockEarnings":[{"period":"1week","weight":-0.1079},{"period":"1month","weight":-0.0652},{"period":"3month","weight":-0.1296},{"period":"6month","weight":0.075},{"period":"1year","weight":-0.0966},{"period":"ytd","weight":-0.0632}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京绿竹生物技术股份有限公司是一家主要从事疫苗及治疗性生物制剂的研究、开发及生产的中国公司。该公司还从事开发创新型人用疫苗及治疗性生物制剂,以预防及控制传染病以及治疗癌症及自身免疫性疾病。该公司的产品包括临床阶段的在研产品,以及临床前阶段的在研产品。核心产品LZ901,主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司主要在国内市场开展其业务","exchange":"SEHK","name":"绿竹生物-B","nameEN":"LUZHU BIOTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿竹生物-B,02480,绿竹生物-B股票,绿竹生物-B股票老虎,绿竹生物-B股票老虎国际,绿竹生物-B行情,绿竹生物-B股票行情,绿竹生物-B股价,绿竹生物-B股市,绿竹生物-B股票价格,绿竹生物-B股票交易,绿竹生物-B股票购买,绿竹生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}